Balancing Cancer Immunotherapy Efficacy and Toxicity is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2020). On theSindex it has a DataRank of 0. It has been cited 40 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: K23 CA204726
National Cancer Institute
Grant: R01CA227481
NHLBI NIH HHS
Grant: R01 HL155990
NIDDK NIH HHS
Grant: K23 DK117014
National Institutes of Health
Grant: 5K23CA204726-05
Predicting and profiling long-term survival after immune checkpoint inhibition
National Institutes of Health
Grant: 5R01CA227481-03
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
National Institutes of Health
FWCI
2.21
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals